Tissue Regenix Group Balance Sheet Health
Financial Health criteria checks 5/6
Tissue Regenix Group has a total shareholder equity of $29.3M and total debt of $10.2M, which brings its debt-to-equity ratio to 34.9%. Its total assets and total liabilities are $45.1M and $15.8M respectively. Tissue Regenix Group's EBIT is $363.0K making its interest coverage ratio 0.4. It has cash and short-term investments of $3.5M.
Key information
34.9%
Debt to equity ratio
US$10.25m
Debt
| Interest coverage ratio | 0.4x |
| Cash | US$3.46m |
| Equity | US$29.34m |
| Total liabilities | US$15.78m |
| Total assets | US$45.12m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: LSW's short term assets ($20.9M) exceed its short term liabilities ($5.6M).
Long Term Liabilities: LSW's short term assets ($20.9M) exceed its long term liabilities ($10.2M).
Debt to Equity History and Analysis
Debt Level: LSW's net debt to equity ratio (23.1%) is considered satisfactory.
Reducing Debt: LSW's debt to equity ratio has increased from 20.2% to 34.9% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: LSW has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: LSW has sufficient cash runway for 2.4 years if free cash flow continues to grow at historical rates of 34% each year.